Literature DB >> 2153203

Structure-activity relationships of N2-substituted guanines as inhibitors of HSV1 and HSV2 thymidine kinases.

C Hildebrand1, D Sandoli, F Focher, J Gambino, G Ciarrocchi, S Spadari, G Wright.   

Abstract

A series of N2-phenylguanines was synthesized and tested for inhibition of the thymidine kinases encoded by Herpes simplex viruses type 1 and type 2. Compounds with hydrophobic, electron-attracting groups in the meta position of the phenyl ring such as m-trifluoromethyl (m-CF3PG, IC50 = 0.1 microM) were the most potent inhibitors of both enzymes. Many derivatives were significantly more potent against the type 2 thymidine kinase, and can effectively discriminate between the two enzymes. Among other N2-substituted guanines, alkyl and benzyl derivatives were moderately potent inhibitors, and the type 2 enzyme was again more sensitive than the type 1 enzyme. None of the compounds inhibited the thymidine kinase isolated from the host HeLa cell line, suggesting that members of this class of compounds may be useful nonsubstrate, antiviral compounds for latent herpesvirus infections.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153203     DOI: 10.1021/jm00163a033

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Specific inhibitors of herpes simplex virus thymidine kinase diminish reactivation of latent virus from explanted murine ganglia.

Authors:  D A Leib; K L Ruffner; C Hildebrand; P A Schaffer; G E Wright; D M Coen
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

2.  Prediction of the binding mode of N2-phenylguanine derivative inhibitors to herpes simplex virus type 1 thymidine kinase.

Authors:  A C Gaudio; Y Takahata; W G Richards
Journal:  J Comput Aided Mol Des       Date:  1998-01       Impact factor: 3.686

3.  Prodrugs of herpes simplex thymidine kinase inhibitors.

Authors:  Milka Yanachkova; Wei-Chu Xu; Sofya Dvoskin; Edward J Dix; Ivan B Yanachkov; Federico Focher; Lida Savi; M Dulfary Sanchez; Timothy P Foster; George E Wright
Journal:  Antivir Chem Chemother       Date:  2015-10-13

4.  Inhibition of herpes simplex virus thymidine kinases by 2-phenylamino-6-oxopurines and related compounds: structure-activity relationships and antiherpetic activity in vivo.

Authors:  Andrzej Manikowski; Annalisa Verri; Andrea Lossani; Bryan M Gebhardt; Joseph Gambino; Federico Focher; Silvio Spadari; George E Wright
Journal:  J Med Chem       Date:  2005-06-02       Impact factor: 7.446

5.  Lack of stereospecificity of suid pseudorabies virus thymidine kinase.

Authors:  G Maga; A Verri; L Bonizzi; W Ponti; G Poli; A Garbesi; D Niccolai; S Spadari; F Focher
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

6.  Trichomonas vaginalis thymidine kinase: purification, characterization and search for inhibitors.

Authors:  S Strosselli; S Spadari; R T Walker; I Basnak; F Focher
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

7.  N2-Phenyl-9-(hydroxyalkyl)guanines and related compounds are substrates for Herpes simplex virus thymidine kinases.

Authors:  Andrea Lossani; Lida Savi; Andrzej Manikowski; Andrew Maioli; Joseph Gambino; Federico Focher; Silvio Spadari; George E Wright
Journal:  J Mol Biochem       Date:  2012

8.  Identification, partial purification and inhibition by guanine analogues of a novel enzymic activity which phosphorylates guanosine to GMP in the protozoan parasite Eimeria tenella.

Authors:  G Maga; S Spadari; G E Wright; F Focher
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

9.  Kinetic studies with N2-phenylguanines and with L-thymidine indicate that herpes simplex virus type-1 thymidine kinase and thymidylate kinase share a common active site.

Authors:  G Maga; F Focher; G E Wright; M Capobianco; A Garbesi; A Bendiscioli; S Spadari
Journal:  Biochem J       Date:  1994-08-15       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.